CYP3A4 and metabolic dysfunction-associated steatotic liver disease: Moreover, genetic variants in other factors implicated in NAFLD, endobiotic, and xenobiotic metabolism such as PXR, PPARα, and POR have also been associated with altered CYP3A4 expression and activity (Zhang et al., 2008; Gomes et al., 2009; Klein et al., 2012).